Mdck suspension cell lines in serum-free, chemically-defined media for vaccine production
AssigneesNational Health Research Institutes, FUJIFILM Irvine Scientific, Inc.
InventorsJenny BANG, Hsiao-Tzu NI, Alan Yung-Chih HU, Tsai-Chuan WENG
Life of this patent
Estimating the term…
Abstract
Disclosed is an adapted Madin-Darby canine kidney cell line capable of suspension culture in the absence of serum, and a chemically-defined medium for culture of the adapted MDCK cell line. Further disclosed are culture methods for growing the adapted MDCK cell line and methods for producing a vaccine from the adapted MDCK cell line grown in the chemically-defined medium.
Claims21
-32. (canceled)
A method of culturing adapted Madin-Darby canine kidney (MDCK) cells comprising contacting adapted MDCK cells with chemically-defined and animal component free growth medium at 5% CO2.
A method for producing an isolated suspension and serum free adapted Madin-Darby canine kidney (MDCK) cell line comprising:
- (a) contacting adherent MDCK cells with a growth medium comprising serum for a period of time sufficient to establish the adherent MDCK cells in culture;
- (b) contacting the established adherent MDCK cells with chemically-defined growth medium to establish adapted MDCK cells in culture;
- and
- (c) isolating the adapted MDCK cells thereby producing an isolated suspension and serum free adapted MDCK cell line.
Dependencies are inferred from the claim text.